Categories AlphaGraphs, Earnings, Health Care
Earnings: All you need to know about Agilent Technologies’ Q3 2023 results
Agilent Technologies (NYSE: A) on Tuesday reported mixed results for the third quarter of 2023 when the medical device company’s adjusted earnings increased despite a drop in revenues.
The Santa Clara-based company said its third-quarter profit, on an adjusted basis, rose to $1.43 per share from $1.34 per share in the year-ago period.
Unadjusted net income was $111 million or $0.38 per share in Q3, compared to $329 million or $1.10 per share in the corresponding quarter of 2022. At $1.67 billion, revenues were down 2.7% from last year.
“Looking forward, we believe the current market environment is transitory, and are confident in our team and the long-term growth prospects of our end markets,” said Agilent’s CEO Mike McMullen.
Prior Performance
Most Popular
CVX Earnings: Chevron reports lower revenue and profit for Q1 2024
Energy exploration company Chevron Corporation (NYSE: CVX) announced first-quarter 2024 financial results, reporting a decline in net profit and revenues. Net income attributable to Chevron Corporation was $5.50 billion or
ABBV Earnings: AbbVie reports lower adj. profit for Q1 2024; revenue edges up
Specialty biopharmaceutical company AbbVie, Inc. (NYSE: ABBV) Friday announced first-quarter 2024 financial results, reporting a decline in adjusted earnings and a modest rise in revenues. The company reported worldwide net
CL Earnings: Key quarterly highlights from Colgate-Palmolive’s Q1 2024 financial results
Colgate-Palmolive Company (NYSE: CL) reported first quarter 2024 earnings results today. Net sales increased 6.2% year-over-year to $5.06 billion. Organic sales increased 9.8%. Net income attributable to Colgate-Palmolive Company was